BCL10 and neoplasm: These computational findings collectively indicate that BCL10 may orchestrate an immunosuppressive TIME by dual mechanisms: suppressing anti-tumor immunity via cytotoxic cell inhibition and amplifying immune tolerance through Treg/CD4+ Th2 cells potentiation (46, 47).